BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38390699)

  • 21. All That Is Small Is Not a Small-Cell Carcinoma: Thoracic SMARCA4-Deficient Undifferentiated Tumors Masquerading as SCLC.
    Rekhtman N
    Clin Cancer Res; 2024 May; 30(9):1708-1711. PubMed ID: 38416596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas.
    Rekhtman N; Montecalvo J; Chang JC; Alex D; Ptashkin RN; Ai N; Sauter JL; Kezlarian B; Jungbluth A; Desmeules P; Beras A; Bishop JA; Plodkowski AJ; Gounder MM; Schoenfeld AJ; Namakydoust A; Li BT; Rudin CM; Riely GJ; Jones DR; Ladanyi M; Travis WD
    J Thorac Oncol; 2020 Feb; 15(2):231-247. PubMed ID: 31751681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors.
    Gantzer J; Davidson G; Vokshi B; Weingertner N; Bougoüin A; Moreira M; Lindner V; Lacroix G; Mascaux C; Chenard MP; Bertucci F; Davidson I; Kurtz JE; Sautès-Fridman C; Fridman WH; Malouf GG
    Oncologist; 2022 Jun; 27(6):501-511. PubMed ID: 35278076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
    Guo J; Liao Z; Chen Q; Dong A; Huang M
    Clin Nucl Med; 2023 Dec; 48(12):1111-1113. PubMed ID: 37882056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report.
    Iijima Y; Sakakibara R; Ishizuka M; Honda T; Shirai T; Okamoto T; Tateishi T; Sakashita H; Tamaoka M; Takemoto A; Kumaki Y; Ikeda S; Miyazaki Y
    Immunotherapy; 2020 Jun; 12(8):563-569. PubMed ID: 32363992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor.
    Lin Y; Yu B; Sun H; Zhang H; Hu Z; Zhang Y; Wu Z; Sun S; Zhao X; Yu H; Wu X; Li Y; Wang J; Wang H
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8663-8671. PubMed ID: 37115272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
    Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
    Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources.
    Kuwamoto S; Matsushita M; Takeda K; Tanaka N; Endo Y; Yamasaki A; Kohashi K; Oda Y; Horie Y
    Hum Pathol; 2017 Dec; 70():92-97. PubMed ID: 28601660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMARCA4-Deficient Undifferentiated Tumor of Lung Mass-A Rare Tumor With the Rarer Occurrence of Brain Metastasis: A Case Report and Review of the Literature.
    Yadav R; Sun L; Salyana M; Eric M; Gotlieb V; Wang JC
    J Investig Med High Impact Case Rep; 2022; 10():23247096221074864. PubMed ID: 35356840
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Nakra T; Kakkar A; Mathur SR; Jain D; Kumar S
    Int J Surg Pathol; 2023 Feb; 31(1):104-109. PubMed ID: 35466749
    [No Abstract]   [Full Text] [Related]  

  • 31. Thoracic SMARCA2-deficient But SMARCA4-preserved Tumors With Undifferentiated Morphology Combined With Claudin-4 Negativity.
    Iwakoshi A; Sasaki E; Sato M; Sugiyama K; Kogure Y; Kitagawa C; Nishimura R
    Am J Surg Pathol; 2022 Jul; 46(7):1000-1006. PubMed ID: 35220352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.
    Perret R; Chalabreysse L; Watson S; Serre I; Garcia S; Forest F; Yvorel V; Pissaloux D; Thomas de Montpreville V; Masliah-Planchon J; Lantuejoul S; Brevet M; Blay JY; Coindre JM; Tirode F; Le Loarer F
    Am J Surg Pathol; 2019 Apr; 43(4):455-465. PubMed ID: 30451731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.
    Longo V; Catino A; Montrone M; Montagna ES; Pesola F; Marech I; Pizzutilo P; Nardone A; Perrone A; Gesualdo M; Galetta D
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy.
    Zhou P; Fu Y; Tang Y; Jiang L; Wang W
    Lung Cancer; 2024 Mar; 189():107471. PubMed ID: 38306886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytopathological Features of
    Takeda M; Tani Y; Saijo N; Shimizu S; Taniguchi Y; Otsuka K; Nakao K; Tamiya A; Okishio K; Atagi S; Ohbayashi C; Kasai T
    Int J Surg Pathol; 2020 Feb; 28(1):109-114. PubMed ID: 31448657
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous metastasis of SMARCA4-deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications.
    Leckey BD; Selim MA; Al-Rohil RN
    J Cutan Pathol; 2020 Jun; 47(6):561-565. PubMed ID: 31995235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.
    Matsushita M; Kuwamoto S
    Acta Cytol; 2018; 62(5-6):456-462. PubMed ID: 30286456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors.
    Luo J; Ding B; Campisi A; Chen T; Teng H; Ji C
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4455-4463. PubMed ID: 36121510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma].
    Asou C; Maeda T; Yamaguchi O; Okamura D; Ishikawa M; Kohri M; Tsukasaki K; Matsuda A; Asou N; Satoh T; Kayano H; Takahashi N
    Rinsho Ketsueki; 2023; 64(4):271-276. PubMed ID: 37121771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding the Immunophenotype Spectrum of SMARCA4-Deficient Non-Small Cell Lung Carcinomas: A Case Series with Neuroendocrine Markers Expression.
    Mao R; Liu M; Shu X; Li W; Yan W; Li X
    Int J Surg Pathol; 2022 May; 30(3):251-259. PubMed ID: 34633874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.